Celularity (CELU) Competitors $2.10 -0.23 (-9.87%) Closing price 04:00 PM EasternExtended Trading$2.10 +0.00 (+0.24%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELU vs. FTLF, NKTX, CYBN, TNGX, NLTX, EPRX, ACRS, ADCT, LRMR, and EDITShould you be buying Celularity stock or one of its competitors? The main competitors of Celularity include FitLife Brands (FTLF), Nkarta (NKTX), Cybin (CYBN), Tango Therapeutics (TNGX), Neoleukin Therapeutics (NLTX), Eupraxia Pharmaceuticals (EPRX), Aclaris Therapeutics (ACRS), ADC Therapeutics (ADCT), Larimar Therapeutics (LRMR), and Editas Medicine (EDIT). These companies are all part of the "pharmaceutical products" industry. Celularity vs. FitLife Brands Nkarta Cybin Tango Therapeutics Neoleukin Therapeutics Eupraxia Pharmaceuticals Aclaris Therapeutics ADC Therapeutics Larimar Therapeutics Editas Medicine Celularity (NASDAQ:CELU) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, media sentiment, dividends, profitability, valuation and risk. Do institutionals & insiders believe in CELU or FTLF? 19.0% of Celularity shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 22.1% of Celularity shares are owned by company insiders. Comparatively, 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate CELU or FTLF? FitLife Brands has a consensus price target of $20.50, indicating a potential upside of 47.48%. Given FitLife Brands' stronger consensus rating and higher probable upside, analysts clearly believe FitLife Brands is more favorable than Celularity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celularity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is CELU or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to Celularity's net margin of -72.72%. FitLife Brands' return on equity of 28.03% beat Celularity's return on equity.Company Net Margins Return on Equity Return on Assets Celularity-72.72% -119.53% -25.40% FitLife Brands 13.38%28.03%15.13% Which has more risk and volatility, CELU or FTLF? Celularity has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Does the media favor CELU or FTLF? In the previous week, FitLife Brands had 6 more articles in the media than Celularity. MarketBeat recorded 7 mentions for FitLife Brands and 1 mentions for Celularity. Celularity's average media sentiment score of 0.68 beat FitLife Brands' score of 0.04 indicating that Celularity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celularity 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, CELU or FTLF? FitLife Brands has higher revenue and earnings than Celularity. Celularity is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelularity$54.22M0.92-$196.29M-$2.65-0.79FitLife Brands$64.47M2.02$5.30M$0.8416.55 Does the MarketBeat Community believe in CELU or FTLF? Celularity received 5 more outperform votes than FitLife Brands when rated by MarketBeat users. However, 60.00% of users gave FitLife Brands an outperform vote while only 42.11% of users gave Celularity an outperform vote. CompanyUnderperformOutperformCelularityOutperform Votes842.11% Underperform Votes1157.89% FitLife BrandsOutperform Votes360.00% Underperform Votes240.00% SummaryFitLife Brands beats Celularity on 16 of the 19 factors compared between the two stocks. Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELU vs. The Competition Export to ExcelMetricCelularityPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.00M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-0.798.9226.8419.71Price / Sales0.92250.95391.39116.98Price / Cash0.2465.8538.2534.62Price / Book1.006.466.794.50Net Income-$196.29M$143.98M$3.23B$248.18M7 Day Performance3.96%3.04%4.07%1.14%1 Month Performance38.16%7.44%12.52%15.20%1 Year Performance-34.78%-2.46%16.83%6.56% Celularity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELUCelularity0.1969 of 5 stars$2.10-9.9%N/A-25.8%$50.00M$54.22M-0.79220News CoverageFTLFFitLife Brands4.4273 of 5 stars$15.41-1.9%$20.50+33.0%+0.9%$144.61M$64.47M18.2420Earnings ReportNKTXNkarta1.9798 of 5 stars$2.02+4.7%$14.83+634.3%-73.3%$143.34MN/A-1.07140News CoveragePositive NewsEarnings ReportAnalyst RevisionGap UpCYBNCybin2.7493 of 5 stars$6.62-6.1%$86.00+1,199.1%N/A$142.18MN/A-1.5150News CoverageTNGXTango Therapeutics1.5872 of 5 stars$1.31+14.9%$12.33+841.5%-73.0%$141.62M$42.07M-1.1190NLTXNeoleukin TherapeuticsN/A$14.73-1.8%N/A-42.6%$138.43MN/A-4.7490Gap UpHigh Trading VolumeEPRXEupraxia Pharmaceuticals2.2192 of 5 stars$3.86+1.4%$10.50+172.4%+32.2%$138.20MN/A-5.3529Gap UpACRSAclaris Therapeutics2.8746 of 5 stars$1.25-0.8%$10.67+753.3%+13.4%$135.35M$18.72M-2.40100Gap UpADCTADC Therapeutics2.675 of 5 stars$1.35+5.9%$7.75+476.2%-47.8%$133.39M$70.84M-0.56310News CoverageEarnings ReportAnalyst RevisionLRMRLarimar Therapeutics2.0753 of 5 stars$2.08-1.9%$19.63+843.5%-71.7%$133.18MN/A-1.8130Positive NewsEDITEditas Medicine4.2699 of 5 stars$1.54+6.2%$5.73+271.9%-70.3%$128.91M$32.31M-0.60230Positive NewsGap Up Related Companies and Tools Related Companies FTLF Competitors NKTX Competitors CYBN Competitors TNGX Competitors NLTX Competitors EPRX Competitors ACRS Competitors ADCT Competitors LRMR Competitors EDIT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELU) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celularity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.